Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.
about
Nonhuman primate models for HIV/AIDS vaccine developmentAn Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates.HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV.HIV DNA Vaccine: Stepwise Improvements Make a Difference.Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adults.HIV vaccine research and discovery in the nonhuman primates model: a unified theory in acquisition prevention and control of SIV infectionNew developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design.Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models.Trimeric HIV Env provides epitope occlusion mediated by hypervariable loopsImmunogenicity analysis following human immunodeficiency virus recombinant DNA and recombinant vaccinia virus Tian Tan prime-boost immunization.
P2860
Q26861148-18CC6DC9-174E-42F5-AB29-DB825A2BAF69Q30375785-B202A561-0423-4B26-AD07-1ED6954ACBFFQ33869332-FC50811E-D06D-4558-9290-B8FA17FB622AQ35826742-A874EBAD-8821-4223-B8CF-921F4B6B8AFCQ36668517-9A70FED3-21EE-484C-A983-232C588690CDQ38105946-765B94B1-50BC-4CEB-99AD-02A37C1B9273Q38748193-C1EA9D44-5EEA-4FF4-B404-59BFBB6D7B24Q40071705-EB8AEFD5-AE3B-492E-A5D8-86BB3CC4C86AQ42181481-182739B1-ADC9-4447-8A47-B74CBC524008Q44569389-EAECE7E0-C1F8-4CCE-9E30-FCBAE9F676E0
P2860
Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Inclusion of a CRF01_AE HIV en ...... uction after SHIV-E challenge.
@ast
Inclusion of a CRF01_AE HIV en ...... uction after SHIV-E challenge.
@en
type
label
Inclusion of a CRF01_AE HIV en ...... uction after SHIV-E challenge.
@ast
Inclusion of a CRF01_AE HIV en ...... uction after SHIV-E challenge.
@en
prefLabel
Inclusion of a CRF01_AE HIV en ...... uction after SHIV-E challenge.
@ast
Inclusion of a CRF01_AE HIV en ...... uction after SHIV-E challenge.
@en
P2093
P2860
P50
P1433
P1476
Inclusion of a CRF01_AE HIV en ...... uction after SHIV-E challenge.
@en
P2093
David B Weiner
Doan-Trang Pham
Ellen G Kuta
James R Lane
Jean D Boyer
Leigh-Anne Eller
Linda L Jagodzinski
Lydia Hart
Maria G Ferrari
Patricia Earl
P2860
P304
P356
10.1016/J.VACCINE.2011.12.131
P407
P50
P577
2012-01-09T00:00:00Z